METTL14 plays a pivotal role in repressing AML differentiation and maintaining the self-renewal of LSCs by modulating the mRNA stability and translation of MYC and MYB in an m6A-dependent manner, while METTL14 expression is suppressed by SPI1, a master transcription factor (TF). The gene discussed is MYC; the disease is acute myeloid leukemia.